United Therapeutics Corp
XMUN:UTH
United Therapeutics Corp
XMUN:UTH
Price:
464.3
EUR
Market Closed
Market Cap:
€13.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
A
|
Apple Inc
XHAM:APC
|
US |
|
N
|
Norwegian Air Shuttle ASA
OSE:NAS
|
NO |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
D
|
Diageo PLC
PAR:DGE
|
UK |
|
Aker BP ASA
OTC:AKRBF
|
NO |
|
Limbach Holdings Inc
F:J4B
|
US |
|
F
|
Fulton Financial Corp
F:FU5
|
US |
|
Peel Mining Ltd
ASX:PEX
|
AU |
|
InspireMD Inc
NASDAQ:NSPR
|
IL |
|
C
|
China International Capital Corp Ltd
F:CIM
|
CN |
|
Paragon Care Ltd
ASX:PGC
|
AU |
|
Mishra Dhatu Nigam Ltd
NSE:MIDHANI
|
IN |
|
I
|
iRobot Corp
XMUN:I8R
|
US |
|
Pieris Pharmaceuticals Inc
NASDAQ:PIRS
|
US |
|
L
|
LSI Industries Inc
F:LS2
|
US |
|
C
|
Conduent Inc
SWB:4C0
|
US |
|
Eurofins Scientific SE
F:ESF0
|
LU |
Multiples-Based Value
The Multiples-Based Value for 
United Therapeutics Corp (UTH) under the Base Case is hidden
EUR.
Compared with the current market price of 464.3 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
UTH Multiples-Based Value
LOCKED
